Dr. Katherine L Nathanson, MD
Claim this profileUniversity of Pennsylvania
Studies Cancer
Studies Frontotemporal Dementia
2 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Katherine L Nathanson, MD is currently running
Behavioral Nudge
for Genetic Predisposition
Given the expansion of indications for genetic testing and our understanding of conditions for which the results change medical management, it is imperative to consider novel ways to deliver care beyond the traditional genetic counseling visit, which are both amenable to large-scale implementation and sustainable. The investigators propose an entirely new approach for the implementation of genomic medicine, supported by the leadership of Penn Medicine, investigating the use of non-geneticist clinician and patient nudges in the delivery of genomic medicine through a pragmatic randomized clinical trial, addressing NHGRI priorities. Our application is highly conceptually and technically innovative, building upon expertise and infrastructure already in place. Innovative qualities of our proposal include: 1) Cutting edge EHR infrastructure already built to support genomic medicine (e.g., partnering with multiple commercial genetic testing laboratories for direct test ordering and results reporting in the EHR); 2) Automated EHR-based direct ordering or referring by specialist clinicians (i.e., use of replicable modules that enable specialist clinicians to order genetic testing through Epic Smartsets, including all needed components, such as populated gene lists, smartphrases, genetic testing, informational websites and acknowledgement e-forms for patient signature); 3) EHR algorithms for accurate patient identification (i.e., electronic phenotype algorithms to identify eligible patients, none of which currently have phenotype algorithms present in PheKB; 4) Behavioral economics-informed implementation science methods: This trial will be the first to evaluate implementation strategies informed by behavioral economics, directed at clinicians and/or patients, for increasing the use of genetic testing; further it will be the first study in this area to test two forms of defaults as a potential local adaptation to facilitate implementation (ordering vs. referring); and 5) Dissemination: In addition to standard dissemination modalities,PheKB95, GitHub and Epic Community Library, the investigators propose to disseminate via AnVIL (NHGRI's Genomic Data Science Analysis, Visualization, and Informatics Lab-Space). Our results will represent an entirely new paradigm for the provision of genomic medicine for patients in whom the results of genetic testing change medical management.
Recruiting1 award N/A2 criteria
Genetic Testing
for Young Adults with Cancer
This trial uses a broad genetic test and automated computer systems to identify cancer risk in young adult cancer patients and their close relatives. It aims to catch genetic risks that traditional methods might miss, helping doctors manage these risks more efficiently.
Recruiting1 award N/A4 criteria
More about Katherine L Nathanson, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Katherine L Nathanson, MD has experience with
- 66-gene Panel For Young Adult Cancers
- Broad Gene Panel For Young Adult Cancers
- Standard
- Behavioral Nudge
Breakdown of trials Katherine L Nathanson, MD has run
Frontotemporal Dementia
Pheochromocytoma
Paraganglioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katherine L Nathanson, MD specialize in?
Katherine L Nathanson, MD focuses on Cancer and Frontotemporal Dementia. In particular, much of their work with Cancer has involved treating patients, or patients who are undergoing treatment.
Is Katherine L Nathanson, MD currently recruiting for clinical trials?
Yes, Katherine L Nathanson, MD is currently recruiting for 2 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Katherine L Nathanson, MD has studied deeply?
Yes, Katherine L Nathanson, MD has studied treatments such as 66-gene panel for young adult cancers, Broad gene panel for young adult cancers, Standard.
What is the best way to schedule an appointment with Katherine L Nathanson, MD?
Apply for one of the trials that Katherine L Nathanson, MD is conducting.
What is the office address of Katherine L Nathanson, MD?
The office of Katherine L Nathanson, MD is located at: University of Pennsylvania, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the University of Pennsylvania.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.